Top 25 Medical Device Angel Investors in Canada (June 2026)

James Lochrie is an entrepreneur, angel investor, venture capitalist and volunteer. He is the Co-founder of the global fintech company Wave. He is a Partner at Thin Air Labs, overseeing Thin Air Fund 1 and the Capital team. He has worked with thousands of entrepreneurs to help them scale their companies and #BuildWhatsNext.

Investment focus

Industry: Software, SaaS, Analytics
Stage:Seed, Angel, Pre-Seed
Geography: Canada

Investor stats

Total investments: 13
Round size: Seed $1M–$5.1M; Angel $550k–$1.1M; Pre-Seed $274k–$502k
Lead/follow: 23% lead, 77% follow

Portfolio highlights

SomaDetect — SomaDetect measures every critical indicator of dairy quality (fat, protein, somatic cell counts, progesterone) from every cow at every milking. It uses no consumables (no chemicals, no cartridges, no lost milk), is extremely quick (results in seconds, not minutes), and accurate.
PayShepherd — PayShepherd helps manage contractor billing for industrial facilities and simplifies billing processes. Save time, money, and headaches.
StellarAlgo — Drive fan engagement and revenue across the entire fan journey. For Major Leagues, Emerging Leagues, Live Events, Media & Gaming, and Corporate Partnerships.

Show all investments...

Noel Hall is the Director of Corporate of Wellcome Trust. He is a former Board Director, Co-founder, and President of Aspreva Pharmaceuticals Corp. He attended the University of London.

Investment focus

Industry: Biotechnology, Genetics, Life Science
Stage:Seed, Angel
Geography: Canada, United States

Investor stats

Total investments: 3
Round size: Seed $2.5M–$5.5M
Lead/follow: 33% lead, 67% follow

Portfolio highlights

Epistemic AI — At Epistemic AI we are building the next generation of tools to accelerate biomedical research with AI and NLP.We are a group of senior scientists and engineers from the likes of Google, New York University, Stanford and more. We are dedicated to enabling advances in biomedical research and practice with AI and NLP.We are creating a movement ofpeople enthusiastically committed to a new vision for the future of biomedical research and we hope you want to join us.
Incisive Genetics — IG is focused on developing a cutting-edge non-viral delivery platform for genetic therapies. This disruptive and transformational delivery platform enables a one-step encapsulation of the active CRISPR components within lipid nanoparticles. The Company's pre-clinical pipeline includes programs addressing neurologic and ocular geneticdiseases. IG is actively seeking partnerships with pharmaceutical companies developing gene therapies to be enabled by its novel delivery platform.

Show all investments...

Originally trained as a medical doctor, Dr. Ray Muzyka cofounded BioWare, a video game development studio focusing on story and character, in the early 1990s. He practiced emergency/family medicine for two years full time, with medicine transitioning to part-time over the following decade as he focused on his role as BioWare’s CEO. BioWare wasacquired by Electronic Arts in 2007, and Dr. Muzyka took on the roles of Senior Vice President at Electronic Arts and General Manager of EA’s BioWare division, which grew over the next five years to span eight development locations worldwide with about 2000 staff (1400 full time). He retired from video games in October 2012, with his third “career chapter” at ThresholdImpact, where he focused on sustainable, profitable impact investing: mentoring and angel investing in information technology, new media, and medical innovations with social entrepreneurs. An active angel investor and entrepreneurial mentor, Dr. Muzyka is a member of the Young Presidents’ Organization, the A100, the Ashoka Support Network, and the Board of Governors of the University of Alberta (serving as Chair of the Human Resources Committee and on the Learning and Discovery Committee and as a member of the University of Alberta Advancement Council). He is Chair of the University of Alberta’s entrepreneur Venture Mentoring Service, a venture advisor at iNovia Venture Capital, and a member of the Alberta Research and Innovation Advisory Committee and the Alberta Premier’s Advisory Committee on the Economy. He also serves on a number of private company boards. He previously served on the board of the Academy of Interactive Arts and Sciences from 2001-2008 and was on the Board of Trustees of the Stollery Children’s Health Foundation from 2012-2015. He was inducted into the Academy of Interactive Arts and Sciences’ Hall of Fame in 2011 and received the International Game Developers’ Choice Awards 2013 Lifetime Achievement Award. Dr. Muzyka received the inaugural Alumni Innovation Award in 2015 from the University of Alberta. He additionally was named as the 2017 Allard Chair in Business at the MacEwan University’s School of Business and as an Honorary Paul Harris Fellow by Rotary Club International in 2016, in recognition for his philanthropic efforts. Other awards include entry into Canada’s Top 40 under 40 and Ernst and Young’s 2001 Entrepreneur of the Year (IT, Prairies).He obtained his Bachelor of Medical Science from the University of Alberta in 1990, his Doctorate of Medicine from there in 1992, and his MBA from the University of Western Ontario (Ivey School of Business) in 2001.

Investment focus

Industry: Health Care, Software, Information Technology
Stage:Seed, Pre-Seed
Geography: Canada, United States

Investor stats

Total investments: 25
Round size: Seed $320k–$2.5M; Pre-Seed $320k–$1.9M
Lead/follow: 8% lead, 92% follow

Portfolio highlights

Leadoptik — Leadoptik is a California-based company is currently operating in stealth mode.
Modality.AI, Inc. — Modality.ai is an AI-powered platform that detects health conditions using conversational AI. Through dialogue and video, Modality.AI interacts conversationally with the patient to provide health assessment anywhere, anytime. Its system analyzes multimodal data which allows continuous screening and assessing of patients’ health.
Gray Oncology Solutions — Gray Oncology Solution is a healthcare enterprise software company that commercializes GrayOS, the operating system for oncology.

Show all investments...

Paul Buchheit is based out of Mountain View, California and is the Co-Founder and General Partner of Standard Capital. Paul Buchheit attended Case Western Reserve University.

Investment focus

Industry: Software, E-Commerce, Health Care
Stage:Seed, Series A, Angel
Geography: United States, Canada, India

Investor stats

Total investments: 152
Round size: Seed $1.1M–$5M; Angel $100k–$1.6M; Series A $2.5M–$13M
Lead/follow: 6% lead, 94% follow

Portfolio highlights

SiPhox Health — Painless, 5-minute biomarker testing at home. Clear insights, trend tracking, and a personalized plan built around your results.
BuildForever — BuildForever build products that feel personal, magical and deeply human.
Perplexity — Perplexity is a search engine platform that uses artificial intelligence to provide large language models and search engines. The company's platform enables the development of beneficial artificial general intelligence, as well as an open-source environment that is accessible to the public, allowing clients to develop skills and knowledge inartificial intelligence.

Show all investments...

Dr. Fong is a Professor Emeritus at the Faculty of Medicine, University of Calgary. He was formerly the Head of the Department of Radiology at the University of Calgary and the Calgary Health Region. Dr. Fong is active in funding and nurturing start-up companies. Over the past two decades, he funded over 50 companies in diverse technology sectors,with an emphasis in medical devices. Dr. Fong is the co-founder and board member of Calgary Scientific Inc. and is also on the board of Clarius Mobile Health, Cohesic Inc. and Innovere Medical. In addition to seed investing, Dr. Fong is active in the Calgary community sitting on six charitable boards and foundations.In 2015, Dr. Fong joined the Creative Destruction Lab (CDL) at the University of Toronto business school as a mentor. CDL helps young entrepreneurs to shape or pivot their nascent ideas. He is widely credited with launching CDL at the Haskayne School of Business at the University of Calgary, bringing together seasoned business leaders from Alberta, Canada and the US to grow budding companies. Dr. Fong is on the Strategic Advisory Board of CDL and a Fellow of CDL in Toronto, Montreal, Calgary and Vancouver. In 2017, Dr. Fong was named to the Order of Canada for his contribution to medical technology innovation and philanthropy.

Investment focus

Industry: Software, Artificial Intelligence, Biotechnology
Stage:Seed, Angel, Pre-Seed
Geography: Canada, Singapore, United States

Investor stats

Total investments: 12
Round size: Seed $227k–$9.3M
Lead/follow: 0% lead, 100% follow

Portfolio highlights

Oncoustics AI — Oncoustics is creating and deploying advanced AI solutions for low cost, non-invasive surveillance, diagnostics, and treatment monitoring of diseases with high unmet clinical need. Unlike other players in the space, Oncoustics does not do image recognition. Instead, Oncoustics applies AI to raw ultrasound signals from readily available handheldultrasound devices to rapidly differentiate healthy versus diseased tissues. There's a wealth of information in these raw signals and this approach reveals novel biomarkers that can be aligned with existing standards and categorization systems. Initially targeting liver disease, a $30B global diagnostic market, Oncoustics has filed a Breakthrough Device Designation Request with the FDA for the OnX that detects liver fibrosis and the 510K is underway. Several follow-on liver products are in development. Oncoustics also has clinical data on other organ indications including prostate, kidney, breast and thyroid diseases and cancers.
SunGreenH2 — SunGreenH2 creates the world's highest performance advanced materials for electrolysis i.e. green hydrogen production. Achieve high efficiency, low cost green H2 production on site for your application in the Power-to-X, Hydrogen refuelling, Energy Storage and Buildings sectors. Revolutionising zero emissions and improving profitability.
EZee Assist — EZee Assist provides instant answers to franchisee operational questions. Continue using preferred channels of support and start receiving instant answers.

Show all investments...

Recognized by Business Insider in 2025 as “one of the top 100 early-stage investors,” Dr. Alucozai has experience translating exceptional science and technology into scalable commercial ventures. Alongside his experience as a founder and operator, he has actively invested in over 100 startups across North America and Europe. He has often been thefirst investor to back high-growth companies like Seqera Labs. Milad began his career as a neuroscientist at the intersection of bioengineering, computational biology, and machine learning, where he commercialized platforms designed to deliver promising medicines to patients more efficiently and safely. His focus as an investor has been to accelerate the journey of groundbreaking discoveries from the lab to the market, particularly in the life sciences sector and related computational fields.Milad is a co-founder and General Partner at Pamir Ventures, an early-stage venture firm that invests in technical pioneers developing B2B companies utilizing AI in antiquated industries. He is also a co-founder of Revalia Bio, which aims to establish a human-centric infrastructure for drug discovery and development. By using non-transplantable human organs donated for research, Revalia offers the scientific community unparalleled insights into patient biology, ultimately aiding in the creation of improved treatments and cures. Throughout his operating and investing career, Milad has played a crucial role in helping founders secure hundreds of millions in capital and facilitating over $1 billion in startup-pharma partnerships. His previous roles include supporting business development at Accenture, Absci, Bit Bio, Numerate, Mekonos, and AstraZeneca. Through Digitalis Commons, he was an Expert in Residence in support of the Advanced Research Projects Agency for Health (ARPA-H), where he aided the US government and ARPA-H mission to enable transformative biomedical and health breakthroughs, providing health solutions through $1.5 billion in non-dilutive investments. He was a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine. He graduated Phi Beta Kappa with a degree in Neuroscience from Purdue University’s Honors Program, earned a master’s in Immunology and Public Health as a George J. Mitchell Scholar, and holds a doctorate from the Richard M. Fairbanks School of Public Health. Additionally, he completed a Visiting Scholar appointment at the Wyss Institute at Harvard University.

Investment focus

Industry: Biotechnology, Health Care, Medical
Stage:Seed, Series A, Pre-Seed
Geography: United States, Canada, United Kingdom

Investor stats

Total investments: 54
Round size: Seed $150k–$6.7M; Pre-Seed $110k–$1.5M; Series A $13M–$55M
Lead/follow: 9% lead, 91% follow

Portfolio highlights

Future Fields — Future Fields Cellular Agriculture: Serum-Free Growth Media Supplements and Recombinant Proteins - Optimized for the Future of Food.
Eigen Therapeutics — Eigen Therapeutics is a biotechnology company developing combination therapeutics for cancer. The company is in the research and development of synergistic therapies that improve efficacy while reducing the toxicity of small molecule therapies and immunotherapies, enabling physicians to get access to novel drugs in areas of unmet medical needs.
Endpoint Health — Endpoint Health is a precision-first therapeutics company. By rewriting the molecule-first drug development model, we aim to deliver precision therapies that have the potential to improve outcomes for patients with immune-driven illnesses.

Show all investments...

Dr. Gaurav Puri graduated from Himachal Dental College in 2002. Following the same career path as Dr. Dhir, they have worked together their entire careers. As the Chief Dental Officer, Dr. Puri spends the vast majority of this time working in the practices. He routinely works with associate providers to increase their skills and ability. He alsotakes on the most challenging cases.

Investment focus

Industry: Robotics, Health Care, Social Impact
Stage:Seed
Geography: Canada

Investor stats

Total investments: 1
Lead/follow: 0% lead, 100% follow

Portfolio highlights

Able Innovations — Able Innovations is developing advanced medical devices to tackle the pressing problem of patient transfer in healthcare.

Show all investments...

Yoshua Bengio (PhD in CS, McGill University, 1991), post-docs at M.I.T. (Michael Jordan) and AT&T Bell Labs (Yann LeCun), CS professor at Université de Montréal, Canada Research Chair in Statistical Learning Algorithms, NSERC Chair, CIFAR Fellow, member of NIPS foundation board and former program/general chair, co-created ICLR conference,authored two books and over 300 publications, the most cited being in the areas of deep learning, recurrent networks, probabilistic learning,natural language and manifold learning. He is among the most cited Canadian computer scientists and is or has been associate editor of the top journals in machine learning and neural networks.

Investment focus

Industry: Artificial Intelligence, Software, Health Care
Stage:Seed, Pre-Seed, Series A
Geography: Canada, France, United States

Investor stats

Total investments: 7
Round size: Seed $1.5M–$11M; Pre-Seed $1.5M–$2.3M
Lead/follow: 14% lead, 86% follow

Portfolio highlights

Entalpic — Entalpic is an AI-driven discovery platform for sustainable industries aiming to optimize carbon-intensive sectors.
Reliant AI — Simplify the labor-intensive process of collecting, organizing, and inspecting vast amounts of complex data. Built for the life sciences. 100% confidence, every time.
Abridge — For patients, clinicians, and enterprise, our audio-based solutions capture the details and summarize medical conversations, anywhere care happens.

Show all investments...

34-year-old Manjit Minhas is the co-founder and co-owner of Minhas Breweries and Distillery and a Dragon on Dragon's Den. Though trained as a petroleum engineer, she has become a specialist in brand development, marketing, sales management and retail negotiations, having been recognized for several business industry awards such as PROFITmagazine's "Top Growth Entrepreneur", Top 100 Women Entrepreneurs in Canada, Calgary's Top 40 under 40, Chatelaine Magazine's "Top Entrepreneur Woman of The Year 2011" and The Sikh Centennial Foundation Award 2014.When Manjit Minhas was 19 years old, she and her brother Ravinder scraped together $10,000 to launch their first beer in Alberta. In 2006, they purchased the second oldest brewery in the United States and renamed it "Minhas Craft Brewery." At the time, this acquisition officially made the Minhas siblings the youngest brewery owners in the world.Their brewery in Monroe, Wisconsin is now the 10th largest in North America, and as a brand they produce more than 90 beers, spirits, liqueurs and wines that ship all across Canada and the U.S., as well as overseas to 15 different countries. Minhas Brewery makes all of the Kirkland brand beer for Costco worldwide, as well as all the craft beers under Trader Joes' label in the US. Today they run a group of companies that generated over $155-million in revenue last year.Manjit lives in Calgary, where she was born and raised, with her husband and two young daughters.

Investment focus

Industry: Health Care, Solar, Energy
Stage:Angel
Geography: Canada

Investor stats

Total investments: 5
Round size: Angel $73k–$200k
Lead/follow: 80% lead, 20% follow

Portfolio highlights

ONES —
7 Fathoms — Seaweed Skin Care Formulated to Nourish and Hydrate the Skin. Anti-Aging, Anti-Inflammatory Skin Care using Seaweed Harvested off the Coast of Grates Cove, Newfoundland.
PilotsFriend West — Precision crafted by bio-scientists and nutritionists, originally made for active duty jet pilots, PilotsFriend is a vitalizing energy tonic that promotes optimal concentration, performance, and health.

Show all investments...

Jacky is dedicated to angel investment and has built up a portfolio of more than thirty startup companies in Canada and the US. His target investments are the early-stage B2B companies with disruptive technologies and business potential in enterprise software, information technologies, MedTech, and Advanced Manufacturing.Jacky has acquiredconcrete business experiences as a successful founder in the startup ecosystem and an executive of Fortune 500 companies over two decades. His remarkable accomplishments range from building startups from scratch to leading a billion-dollar business with the leverage of 14,000 enterprise channel partners. The unique journey has shaped Jacky's outstanding of investing in early startups.Jacky holds the degrees of Mater's E.E. and MBA, and he graduated from CEIBS and The Wharton Business School of the University of Pennsylvania.

Investment focus

Industry: Software, Health Care, Information Technology
Stage:Seed, Pre-Seed
Geography: Canada, United States, China

Investor stats

Total investments: 20
Round size: Seed $500k–$3.1M; Pre-Seed $362k–$1.8M
Lead/follow: 0% lead, 100% follow

Portfolio highlights

Workwolf — Workwolf is a Toronto-based start-up with a management team who has led 7 start-ups, had 2 successful exits, and has taken a company public with a $1.8B IPO. Workwolf CEO Erik Simins is an SME in HR who previously founded MAGNUS HRS, a staffing company now servicing over 150 enterprise customers. The technology at Workwolf solves two of the biggestpain points in employment: applicant filtration and verification, and does so by empowering users to identify better candidates faster. Winner of global awards in both 2020 and 2021 for innovation and market potential, Workwolf is ramping up for its multi-national roll-out with ManpowerGroup in September that will coincide with a $4.5M Seed financing round.
Agile Devices — Agile Devices offer catheter-based interventional procedures helping patients during a stroke. It helps medical practitioners reduce the procedure time to respond to time bound emergencies.
Traction Technology Partners — Traction is a powerful SaaS collaboration platform for evaluating, adopting and managing new technologies across the enterprise. The platform includes Project Management and CRM tools designed specifically for enterprise teams tasked with discovering and evaluating new technologies. Traction is used by IT, Innovation and Corp Dev teams toaccelerate their digital transformation projects, and to speed up the way they find, manage, and adopt new technologies. Traction also offers On-Demand Research services delivered through its platform.

Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Andres Pinter is a Techstars Mentor and angel investor based in Los Angeles, CA.

Investment focus

Industry: Electronics, Health Care, Medical Device
Geography: Canada

Investor stats

Total investments: 1
Lead/follow: 0% lead, 100% follow

Portfolio highlights

GestSure — GestSure was created to solve the problem of in-OR sterile information access. Using cutting-edge machine vision technology, GestSure empowers surgeons to achieve better patient care while saving time and resources.Their system provides a touchless interface that enables surgeons to navigate their patient information using simple hand gestures.From within the sterile field, the surgeon can use a simple set of gestural commands to control their existing software. The simple plug-and-play system is compatible with all medical imaging viewers and requires minimal hospital IT support.

Show all investments...

Paul Geyer, a successful Medtech Entrepreneur and experienced Board member. Over the past 20 years Paul founded and led two companies through their growth phase, in one case to a successful private exit and in the other case through growth as a public company with numerous acquisitions. Both companies have grown to be anchor medical devicecompanies in the Vancouver area, employing more than 350 people.In 1991 he founded Mitroflow International Inc., a tissue heart valve company. Paul grew the company from 9 employees to more than 125 employees in 1999. In 1999 Paul sold Mitroflow to Sulzer Medica, for more than $50 mil. Paul's leadership resulted in Mitroflow growing to more than 200 employees, making it one of the largest medical devices companies in the Vancouver area. In 2001 Paul started Medical Ventures, a new specialty vascular device company where he is currently Chairman of the Board. From its inception to June 2008, Geyer held the position of CEO at Medical Ventures (now Neovasc) and was responsible for raising over $40 million in Equity financing and growing the company’s product portfolio through internal development and the acquisition of 3 other companies. In 2008 Paul began focusing on sharing is expertise to assist other Entrepreneurs to build successful businesses, through his involvement as a mentor or Board member. He also focused on building the local community through his involvement as a Board member of BC technology industry association, along with a number of non-profit community based organizations. Paul is actively engaged as a Philanthropist, as Chairman of the Board of Social Venture Partners Vancouver, involved with Science World, Entrepreneurship at UBC, Project Somos Children’s Village and other organizations.Paul is currently the CEO of LightIntegra Technology Inc., a spin-off from Canadian Blood Services which has developed the ThromboLux technology, used to determine platelet quality for blood transfusions.

Investment focus

Industry: Health Care, Fitness, Wellness
Stage:Seed, Series A
Geography: Canada, United States

Investor stats

Total investments: 8
Round size: Seed $1.1M–$6M
Lead/follow: 25% lead, 75% follow

Portfolio highlights

Stoko design — Get the same level of joint support as a rigid knee brace in the form of a compression tight. Covered by insurance. Fast & free shipping. Hassle-free returns. Backed by orthopedic surgeons. Recommended by Olympians.
Arbutus Medical — Arbutus Medical manufactures medical devices that simplifies orthopedic surgery and reduce the cost of healthcare to help treat patients worldwide.
HeadCheck Health — HEADCHECK HEALTH simplifies the process of executing and monitoring concussion protocols. Learn more!

Show all investments...

Ross Finlay, a Co-founder and Director of the First Angel Network Association has been an angel investor since 2000. He has assisted many companies in raising private equity. Mr. Finlay is a recognized facilitator, senior business consulting professional and strategic change consultant who has an extensive background in public, private andnot-for-profit sectors. He has implemented major business changes in a number of organizations and has experience in conducting organizational reviews in the public/private and the not-for-profit sectors. He has extensive business networks throughout Atlantic Canada. He has been Executive Director of a provincial professional association and President of a national consulting company working with scientific, engineering and technical areas. Since his move home to Nova Scotia, Ross has managed his own successful consulting practice. He returned to the corporate world for a time with PricewaterhouseCoopers LLP and SolutionInc Ltd. – a Halifax based software development company. In 2002 Ross was a recipient of the Queen Elizabeth II Jubilee Medal for outstanding community service through his efforts in numerous charities.

Investment focus

Industry: Energy, Aerospace, CleanTech
Stage:Seed
Geography: Canada

Investor stats

Total investments: 1
Lead/follow: 0% lead, 100% follow

Portfolio highlights

Meta Materials — META® delivers previously unachievable performance, across a range of applications, by inventing, designing, developing, and manufacturing sustainable, highly functional materials. Our extensive technology platform enables leading global brands to deliver breakthrough products to their customers in consumer electronics, 5G communications, healthand wellness, aerospace, automotive, and clean energy. Our nano-optic technology provides anti-counterfeiting security features for government documents and currencies and authentication for brands. Our achievements have been widely recognized, including being named a Lux Research Innovator of the Year in 2021. Learn more at www.metamaterial.com.

Show all investments...

Ryan Pawell (Founder, Director & Chief Executive Officer) is a Y Combinator alumni, published author and subject matter expert in the areas of fluid dynamics, advanced manufacturing, and biomicrofluidics. Ryan has been invited to present his work by the Australian National Fabrication Facility, White House Cancer Moonshot Taskforce, Air Force,National Institutes of Health, and National Cancer Institute among others.

Investment focus

Industry: Medical, Biopharma, Biotechnology
Stage:Seed
Geography: Canada, United States

Investor stats

Total investments: 2
Lead/follow: 0% lead, 100% follow

Portfolio highlights

Pioneer Fund — 300+ YC alumni investing in the top YC startups
Avro — Avro Life Science is developing skin patches for generic drug delivery, focusing on therapeutics for children and the elderly. The core of our technology is a novel biopolymer which is used as a platform for passive transdermal drug delivery of small molecules and drugs.

Show all investments...

Edwin Liang - CTO @ uknowa

Investment focus

Industry: Medical, Software, Health Care
Stage:Seed
Geography: Canada

Investor stats

Total investments: 1
Lead/follow: 100% lead, 0% follow

Portfolio highlights

Swift Medical — Get advanced wound care powered by AI with Swift. 32M+ calibrated images enable 35% faster healing, 79% faster assessments, and 15% fewer hospitalizations.

Show all investments...

Carlo Perez - CEO @ uknowa

Investment focus

Industry: Medical, Software, Health Care
Stage:Seed
Geography: Canada

Investor stats

Total investments: 1
Lead/follow: 100% lead, 0% follow

Portfolio highlights

Swift Medical — Get advanced wound care powered by AI with Swift. 32M+ calibrated images enable 35% faster healing, 79% faster assessments, and 15% fewer hospitalizations.

Show all investments...

Huda is the Founder and CEO of Dot Health, a real-time personal health data platform. With a background in engineering from the University of Toronto and a prolific career at some of Toronto's best known startups including Wattpad, Wave, and Wealthsimple, her latest venture is transforming the way people access and control their own healthinformation for good. Huda's work has been featured in The Globe and Mail, Metro News, CNBC, and Metro Morning. She has been recognized amongst the Top 5 CEOs in Toronto Life and as a Top 25 Women of Influence in 2017.

Investment focus

Industry: Wellness, Fertility, Consumer Goods
Stage:Pre-Seed
Geography: Canada

Investor stats

Total investments: 1
Lead/follow: 0% lead, 100% follow

Portfolio highlights

Lilia — Explore your fertility options & get help with next steps. We research your insurance coverage, lay out the egg freezing process, and can book you into a vetted clinic fast while offering on-demand support.

Show all investments...

Justin Allport

Investment focus

Industry: Medical, Software, Health Care
Stage:Seed
Geography: Canada

Investor stats

Total investments: 1
Lead/follow: 100% lead, 0% follow

Portfolio highlights

Swift Medical — Get advanced wound care powered by AI with Swift. 32M+ calibrated images enable 35% faster healing, 79% faster assessments, and 15% fewer hospitalizations.

Show all investments...

Hugo Larochelle is Research Scientist at Google and Assistant Professor at the Université de Sherbrooke (UdeS).

Investment focus

Industry: Software, Health Care, Medical Device
Stage:Pre-Seed
Geography: Canada

Investor stats

Total investments: 1
Lead/follow: 0% lead, 100% follow

Portfolio highlights

Ubenwa Health — Ubenwa is a medtech company using AI to analyze infant cries, turning devices with microphones into life-saving tools for early health detection. Discover our cutting-edge technology today.

Show all investments...

Wei Guo, the founding partner of UpHonest Capital, is an active angel investor in Silicon Valley, focusing on early-stage cross-sector investments. He founded Wei Fund in 2015 and UpHonest Capital Fund I in 2016, invested in well-known companies such as Hims&Hers(NYSE: HIMS), Vicarious Surgical(NYSE: RBOT), Knightscope (NASDAQ: KSCP), Checkr,Lime, Boom, Rescale, Dialpad and more. Since 2015, he has invested in over 400 Silicon Valley startups, over 76 companies with valuations greater than 100 million USD, and 23 portfolio companies that have successfully exited.

Investment focus

Industry: Software, Artificial Intelligence, Health Care
Stage:Seed, Series A, Angel
Geography: United States, China, Canada

Investor stats

Total investments: 154
Round size: Seed $200k–$4.3M; Angel $375k–$10M; Series A $7M–$19M
Lead/follow: 2% lead, 98% follow

Portfolio highlights

tbh — tbh is a developer of a mobile application designed to provide anonymous feedback to friends. The company's mobile application facilitates asking or answering questions, open text fields and invite abuse when combined with anonymity, enabling users to say things without repercussions and feel better about themselves from the positive feedbackon social networks.
Bungalow — Bungalow is a residential real estate platform that provides renters with a more convenient, flexible, and communal living solution. It utilizes existing housing supply by signing long-term leases with homeowners, and offers multi-bedroom homes in some of the most desirable neighborhoods in cities throughout the United States.Bungalow offersprivate bedrooms with handpicked housemates in beautifully furnished homes across seven major cities. Each home comes furnished and includes wifi, utilities, housekeeping, and monthly community events for members.Andrew Collins and Justin McCarty founded Bungalow in 2016. Its headquarters is in San Francisco in California.
Raydiant — Raydiant empowers brick-and-mortar organizations to deliver engaging, personalized, and measurable on-screen digital experiences to delight in-store customers and engage back-of-house employees.

Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Marc G. Bellemare is the Co-Founder and CSO of Reliant AI. He previously worked at Google as a Research Scientist. Marc G. Bellemare attended the University of Alberta.

Investment focus

Industry: Software, Health Care, Medical Device
Stage:Pre-Seed
Geography: Canada

Investor stats

Total investments: 1
Lead/follow: 0% lead, 100% follow

Portfolio highlights

Ubenwa Health — Ubenwa is a medtech company using AI to analyze infant cries, turning devices with microphones into life-saving tools for early health detection. Discover our cutting-edge technology today.

Show all investments...

Barney Pell was the co-founder, Chairman and Chief Strategy Officer of LocoMobi Inc. Barney has a long history as a leading technology innovator, product visionary, entrepreneur and angel investor based in Silicon Valley. Barney is known for being an Entrepreneur-in-Residence at Mayfield, a top Venture Capital firm, which he left to becomeFounder and CEO of Powerset, which built a natural-language based search engine that read each sentence in Wikipedia and answered user queries in plain English. Microsoft acquired Powerset in 2008 to help create its new search engine, Bing. Barney then served Microsoft as Search Strategist, Evangelist, and Chief Architect for Local Search at Bing, until leaving Microsoft in September 2011 to return to the start-up world full-time.Barney also has active investor, board member, and advisory roles with multiple start-up companies and non-profits across a variety of industries. Barney is Co-Founder, Vice Chairman and Chief Technology Officer of Moon Express, a private company building autonomous robotic lunar landers to enable exploration and commercial development of the solar system. This builds on his earlier career managing advanced software technologies at NASA. Highlights of innovations during Barney’s career at NASA include mission critical software to support planning and collaboration for the Mars Exploration Rovers mission; Clarissa, the first spoken dialog system in space; and the development of the Remote Agent, the first AI system to fly onboard and control a deep space probe. Remote Agent is widely considered one of the top achievements in the history of Artificial Intelligence and was awarded NASA’s "software of the year" award in 1999. Barney is also Associate Founder and Trustee of Singularity University (SU), a new university created to educate leaders for life in a future driven by accelerating technological change.Other recent active angel investments and advisory positions include: Getaround, Robotex, Halcyon Molecular, SpaceX, and CrowdFlower. Recent start-ups that have had successful exits include: Appjet (now Google), Aardvark (now Google), Hot Potato (now Facebook), Etacts (now SalesForce.com), Movity (now Trulia), and LinkedIn, the world’s largest professional social network which recently went public after acquiring its hundred-millionth member.Barney received his Ph.D. in Computer Science from Cambridge University, where he was a Marshall Scholar, and his B.S. degree in Symbolic Systems from Stanford University, where he graduated Phi Beta Kappa and was a National Merit Scholar.Barney is a frequent speaker at conferences and universities. These include keynote talks at the International Joint Conference on Artificial Intelligence, the Association for Computational Linguistics, Search Marketing Expos, International Semantic Web Conference, World Wide Web Conference, the Informational Retrieval Conference, and panels at SXSW Interactive. Barney has also spoken at the NPA and IPI conferences and has been featured in all major Parking industry magazines.

Investment focus

Industry: Mobile, Software, Information Technology
Stage:Seed, Series A, Pre-Seed
Geography: United States, Canada

Investor stats

Total investments: 26
Round size: Seed $750k–$3.4M; Pre-Seed $1.5M–$1.8M; Series A $1.2M–$14M
Lead/follow: 0% lead, 100% follow

Portfolio highlights

Workwolf — Workwolf is a Toronto-based start-up with a management team who has led 7 start-ups, had 2 successful exits, and has taken a company public with a $1.8B IPO. Workwolf CEO Erik Simins is an SME in HR who previously founded MAGNUS HRS, a staffing company now servicing over 150 enterprise customers. The technology at Workwolf solves two of the biggestpain points in employment: applicant filtration and verification, and does so by empowering users to identify better candidates faster. Winner of global awards in both 2020 and 2021 for innovation and market potential, Workwolf is ramping up for its multi-national roll-out with ManpowerGroup in September that will coincide with a $4.5M Seed financing round.
Ada — Ada is a computer software company that features a chatbot-based platform that helps enterprise businesses to automate customer experience. Its platform operates through both web and mobile machine learning engine that reduces support volume and empowers customers to find answers on their own.The company was founded in 2016 and headquartered inToronto in Canada.
Careteam Technologies — Innovating solution that enables virtual care coordination and collaboration within and between health organizations, including the patient, family and community. We enable patient medical home care continuity, care transfers, care pathways, patient engagement, and quality improvement methods using data in health.

Show all investments...

Haig Farris is one of Canada's best-known venture capitalists and experts in high-technology start-ups and turn-arounds, with a varied 30+ year history of involvement, commitment, and management. He has a law degree from the University of Pennsylvania. He is co-founder and former Executive Chair of the Board of Directors of D-Wave, and he isthe President of Fractal Capital, a private venture capital company financing high technology start-ups and resource service technology companies.Previously, Dr. Farris was a co-founder and partner of the Ventures West Management group of venture capital funds (1972-1990). In 2001, he received the British Columbia Technologies Industry Association's (BCTIA) Bill Thompson Award.He was awarded an Honorary Doctor of Laws degree from UBC in 1997 and named A Pioneer of Innovation by the Vancouver Board of Trade in 2001.

Investment focus

Industry: Biotechnology, Genetics, Life Science
Stage:Seed, Pre-Seed
Geography: Canada, United States

Investor stats

Total investments: 2
Lead/follow: 50% lead, 50% follow

Portfolio highlights

Epistemic AI — At Epistemic AI we are building the next generation of tools to accelerate biomedical research with AI and NLP.We are a group of senior scientists and engineers from the likes of Google, New York University, Stanford and more. We are dedicated to enabling advances in biomedical research and practice with AI and NLP.We are creating a movement ofpeople enthusiastically committed to a new vision for the future of biomedical research and we hope you want to join us.
Incisive Genetics — IG is focused on developing a cutting-edge non-viral delivery platform for genetic therapies. This disruptive and transformational delivery platform enables a one-step encapsulation of the active CRISPR components within lipid nanoparticles. The Company's pre-clinical pipeline includes programs addressing neurologic and ocular geneticdiseases. IG is actively seeking partnerships with pharmaceutical companies developing gene therapies to be enabled by its novel delivery platform.

Show all investments...

Sandra MacPherson

Investment focus

Industry: Genetics, Biotechnology, Medical Device
Stage:Seed
Geography: Canada

Investor stats

Total investments: 1
Lead/follow: 100% lead, 0% follow

Portfolio highlights

Incisive Genetics — IG is focused on developing a cutting-edge non-viral delivery platform for genetic therapies. This disruptive and transformational delivery platform enables a one-step encapsulation of the active CRISPR components within lipid nanoparticles. The Company's pre-clinical pipeline includes programs addressing neurologic and ocular geneticdiseases. IG is actively seeking partnerships with pharmaceutical companies developing gene therapies to be enabled by its novel delivery platform.

Show all investments...